DHS started with simple SARS-CoV-2 PCR services for testing centres in Berlin. In 2022, we applied for ISO15189 accreditation at the German Accreditation Body (DAKKS).  During the course of which, we launched a test centre and quickly became a study centre through the founder’s network. Today, we continue to perform contract analysis for one of the largest biobanks in Germany.

With the “First Lab in EU Approach”, we offer manufacturers from non-EU countries initial access to the European market with innovative and reliable diagnostic tests. As part of our “Open Lab Approach”, we also offer medical device manufacturers the opportunity to exhibit their devices at our facility.

The DHS is among the first contacts for conducting clinical performance evaluation studies for in vitro diagnostics in Germany and has already built up a large international network. This network offers DHS versatile opportunities – for example, DHS is the exclusive provider in Germany of the world’s most reliable colorectal cancer screening test from stool samples, is a service provider for the best oncological diagnostics (100 million data points are reduced to a personalised therapy recommendation, early detection test from blood of up to 70 tumours, efficacy testing before chemotherapy, etc.).

Potential clients (routine labs) can visit us to view the device in operating mode and obtain a first impression. The DHS offers versatile opportunities for manufacturers – please feel free to contact us.